Abstract
A new reversed-phase high-performance liquid chromatography (RP-HPLC) method has been developed for the separation and identification of impurities present in metadoxine. Herein, we report that one of the impurities eluted from the metadoxine sample is 4-deoxypyridoxine hydrochloride (4-DPH). In HPLC analysis, the retention time (RT) of 4-DPH was observed to be at 13.5 min in both the reference and metadoxine samples and the relative retention time (RRT) was 1.71. The presence of 4-DPH in a metadoxine sample was also confirmed by a chromatogram obtained by spiking the 4-DPH standard into the sample. Furthermore, the elution and mass of impurity 4-DPH in metadoxine was proven by LC-mass spectroscopy studies. This method highlights the presence of another unknown impurity that has so far not been observed in earlier methods of metadoxine evaluation. Hence, the developed method achieved superior resolution between metadoxine and impurities and thereby facilitates the production of a purer metadoxine drug.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
N. Kaul, H. Agarwal, B. Patil, A. Kakad, and S. R. Dhaneshwar, Chromatographia, 2004, 60, 501.
M. Saravanan, K. S. Kumar, P. P. Reddy, and B. Satyanarayana, Synth. Commun., 2010, 40, 1880.
B. Ramachandra, Crit. Rev. Anal. Chem., 2017, 47, 24.
T. V. Raghava Raju, S. Raja Kumar, A. Srinivas, N. Anil Kumar, I. Mrutyunjaya Rao, and N. Someswara Rao, J. Liq. Chromatogr. Relat. Technol., 2014, 37, 498.
W. Wang, Y. Xu, C. Jiang, and Y. Gao, Curr. Med. Res. Opin., 2018, 35, 261.
K. T. Suk, M. Y. Kim, and S. K. Baik, World J. Gastroenterol., 2014, 20, 12934.
L. Leggio, G. A. Kenna, A. Ferrulli, W. H. Zywiak, F. Caputo, R. M. Swift, and G. Addolorato, Hum. Psychopharmacol. Clin. Exp., 2011, 26, 554.
L. Vonghia, L. Leggio, A. Ferrulli, M. Bertini, G. Gasbarrini, and G. Addolorato, Eur. J. Intern. Med., 2008, 19, 561.
G. Addolorato, C. Ancona, E. Capristo, and G. Gasbarrini, Int. J. Immunopathol. Pharmacol., 2003, 16, 207.
M. M. C. Diaz, A. D. Martinez, V. V. Salcedo, and C. C. Fuentes, J. Int. Med. Res., 2002, 30, 44.
L. S. Shpilenya, A. P. Muzychenko, G. Gasbarrini, and G. Addolorato, Clin. Exp. Res., 2006, 26, 340.
I. Manor, J. H. Newcorn, S. V. Faraone, and L. A. Adler, Postgrad. Med., 2013, 125, 181.
A. C. Childress and C. Tran, Expert Opin. Invest. Drugs, 2016, 25, 463.
G. Mintziori and S. A. Polyzos, Expert Opin. Pharmacother., 2016, 17(14), 1937.
G. Abirami, V. Vaidhyalingam, V. Niraimathi, and A. Aruna, Asian J. Chem., 2009, 21, 1651.
P. Kumar, N. C. Joshi, A. Malik, N. Kaushik, A. Kushnoor, and N. Gowda, Anal. Chem. Ind. J., 2008, 7, 311.
N. Kaul, H. Agarwal, B. Patil, A. Kakad, and S. R. Dhaneshwar, II Farmaco., 2005, 60, 351.
H. Qingchun, H. Chun, J. Yuzhu, L. Daping, L. Lichuan, and H. Ting, Invention Patent Application-Application publication number CN 105566212A, 2016, 05, 11.
Acknowledgements
The authors are thankful to Mr. Mathialagan, Associate Director of Exeltis-India for providing a gift sample of the drug metadoxine. The authors are also thankful to Synthiya Research Labs Private Ltd., Pondicherry, India for providing the laboratory facility.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Suresh Babu, K., Paradesi, D. Investigation of Related Impurities in Metadoxine by a Reversed Phase High Performance Liquid Chromatography Technique. ANAL. SCI. 37, 581–584 (2021). https://doi.org/10.2116/analsci.20P271
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2116/analsci.20P271